Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rapaport

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 1, 1994
CSF inositol in schizophrenia and high-dose inositol treatment of schizophreniaJ Levine, I Goldberger, A Rapaport, et al.
BMC Psychiatry|July 17, 2025
Crisis versus extended care: bimodal distribution of length of stay in psychiatric inpatientsAndreas B Hofmann, Tobias R Spiller, Jeremy A Rapaport, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2000
Botulinum toxin for the treatment of oro-facial-lingual-masticatory tardive dyskinesiaA Rapaport, M Sadeh, D Stein, et al.
The Journal of Investigative Dermatology. Symposium Proceedings|October 25, 2020
Monitoring Response to Platelet-Rich Plasma in Patients with Alopecia Areata with Optical Coherence Tomography: A Case SeriesChloe Ekelem, Margit Juhasz, Junxiao Yu, et al.
Diagnosis (Berlin, Germany)|April 24, 2020
Diagnosis of mast cell activation syndrome: a global "consensus-2"Lawrence B Afrin, Mary B Ackerley, Linda S Bluestein, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 1, 1994
CSF inositol in schizophrenia and high-dose inositol treatment of schizophreniaJ Levine, I Goldberger, A Rapaport, et al.
BMC Psychiatry|July 17, 2025
Crisis versus extended care: bimodal distribution of length of stay in psychiatric inpatientsAndreas B Hofmann, Tobias R Spiller, Jeremy A Rapaport, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2000
Botulinum toxin for the treatment of oro-facial-lingual-masticatory tardive dyskinesiaA Rapaport, M Sadeh, D Stein, et al.
The Journal of Investigative Dermatology. Symposium Proceedings|October 25, 2020
Monitoring Response to Platelet-Rich Plasma in Patients with Alopecia Areata with Optical Coherence Tomography: A Case SeriesChloe Ekelem, Margit Juhasz, Junxiao Yu, et al.
Diagnosis (Berlin, Germany)|April 24, 2020
Diagnosis of mast cell activation syndrome: a global "consensus-2"Lawrence B Afrin, Mary B Ackerley, Linda S Bluestein, et al.
Pageof 4